NCT05341804

Brief Summary

After developing and pilot testing the training program, including the CogBals software, a 3-arm, single-blinded, randomized controlled trial is used to recruit 84 participants and then randomly allocated to the cognitive and balance dual task training group (COG\&BAL), the balance training group (BAL), and the treatment as usual group. The first two training groups (COG\&BAL, BAL) receive training for 60 minutes in a group format, 2 times weekly, for 12 weeks. All participants will be assessed at baseline and posttest. The primary outcome is balance function and secondary outcomes are cognitive functions and the muscular endurance of lower extremities.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
84

participants targeted

Target at P50-P75 for not_applicable schizophrenia

Timeline
Completed

Started May 2022

Shorter than P25 for not_applicable schizophrenia

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 5, 2022

Completed
17 days until next milestone

First Posted

Study publicly available on registry

April 22, 2022

Completed
18 days until next milestone

Study Start

First participant enrolled

May 10, 2022

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 15, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 15, 2023

Completed
Last Updated

June 21, 2024

Status Verified

April 1, 2024

Enrollment Period

1.4 years

First QC Date

April 5, 2022

Last Update Submit

June 19, 2024

Conditions

Outcome Measures

Primary Outcomes (5)

  • Mini-Balance Evaluation System Test

    score from 0-28; higher score is better

    Change from baseline at 12 weeks

  • Timed up and go test under single and dual tasks

    dual tasks include carrying a cup of water and calculation

    Change from baseline at 12 weeks

  • Single leg stance test under single and dual tasks

    dual tasks include carrying a cup of water and calculation

    Change from baseline at 12 weeks

  • Chinese version of Activities-specific Balance Confidence Scale

    score from 0-100; higher score is better

    Change from baseline at 12 weeks

  • 6 meter walk test

    Change from baseline at 12 weeks

Secondary Outcomes (7)

  • Symbol Coding

    Change from baseline at 12 weeks

  • Digit Span

    Change from baseline at 12 weeks

  • Spatial Span

    Change from baseline at 12 weeks

  • The Stroop Color and Word Test

    Change from baseline at 12 weeks

  • Color Trials Test

    Change from baseline at 12 weeks

  • +2 more secondary outcomes

Study Arms (3)

the cognitive and balance dual task training group

EXPERIMENTAL

It is performed using the CogBals software, emphasizing the completion of cognitive tasks while performing balance/strength training during the training process.

Behavioral: cognitive and balance dual task training

the balance training group

EXPERIMENTAL

Balance/strength training without cognitive challenges.

Behavioral: balance training

the treatment as usual group

NO INTERVENTION

Maintain usual rehabilitation activities.

Interventions

a cognitive and balance dual task training program involving the Internet of Thing technique software - Cognitive and Balance training Simultaneously software

Also known as: Use Cognitive and Balance training Simultaneously software (CogBals)
the cognitive and balance dual task training group

Includes static balance, dynamic balance and strength training

the balance training group

Eligibility Criteria

Age40 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • diagnosis of schizophrenia or schizoaffective disorder for more than 1 year by psychiatrist according to Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5)
  • age 40-75 years old
  • have stable psychiatric symptoms currently (main psychotropic medications have not been adjusted for two months
  • being able to ambulate independently for more than 10 meters, without a walking device
  • not have significant cognitive impairment (Montreal Cognitive Assessment Taiwan Version, MoCA≧20)
  • can follow study protocol and sign the informed consent form

You may not qualify if:

  • currently in the psychiatric acute award
  • currently alcohol or drug use disorder
  • Pregnancy, head trauma and other neuromusculoskeletal injuries affect training safety and compliance
  • intellectual disability
  • Unconsciousness or confusion
  • According to the subject's self-report, those with the following medical history, including severe heart failure, myocardial infarction, angina pectoris, chronic obstructive pulmonary disease, poor blood sugar control (i.e., renal dialysis treatment, diabetic neuropathy or retinopathy), no well-controlled hyperemia: systolic blood pressure\> 160 mmHg or diastolic blood pressure\> 110 mmHg
  • Currently participating in other interventional study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kaohsiung Medical University

Kaohsiung City, 807, Taiwan

Location

MeSH Terms

Conditions

SchizophreniaMental Disorders

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
blinded assessor
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: the cognitive and balance dual task training group (COG\&BAL), the balance training group (BAL), and the treatment as usual group
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 5, 2022

First Posted

April 22, 2022

Study Start

May 10, 2022

Primary Completion

September 15, 2023

Study Completion

September 15, 2023

Last Updated

June 21, 2024

Record last verified: 2024-04

Locations